Millennium Management’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-143,459
Closed -$1.15M 7844
2021
Q4
$1.15M Buy
+143,459
New +$1.68M ﹤0.01% 4277
2021
Q3
Sell
-33,956
Closed -$469K 7445
2021
Q2
$469K Buy
33,956
+15,574
+85% +$184K ﹤0.01% 5366
2021
Q1
$166K Buy
18,382
+3,056
+20% +$22.3K ﹤0.01% 5555
2020
Q4
$85K Sell
15,326
-24,224
-61% -$107K ﹤0.01% 5043
2020
Q3
$128 Sell
39,550
-1,157
-3% -$3.87K ﹤0.01% 4182
2020
Q2
$129K Sell
40,707
-911
-2% -$2.75K ﹤0.01% 3941
2020
Q1
$94K Buy
41,618
+670
+2% +$3.07K ﹤0.01% 3559
2019
Q4
$179K Sell
40,948
-11,015
-21% -$51.8K ﹤0.01% 3906
2019
Q3
$265K Buy
51,963
+2,050
+4% +$11.9K ﹤0.01% 3627
2019
Q2
$359K Sell
49,913
-2,362
-5% -$12.8K ﹤0.01% 3443
2019
Q1
$274K Sell
52,275
-4,938
-9% -$24.1K ﹤0.01% 3592
2018
Q4
$88K Sell
57,213
-28,996
-34% -$103K ﹤0.01% 3553
2018
Q3
$349K Buy
+86,209
New +$324K ﹤0.01% 3408
2015
Q3
Sell
-4,023
Closed -$409K 3826
2015
Q2
$409K Buy
+4,023
New +$416K ﹤0.01% 2737
2014
Q2
Sell
-3,125
Closed -$252K 4009
2014
Q1
$252K Buy
+3,125
New +$286K ﹤0.01% 3052

Other funds holding PLXP

Millennium Management's PLXP Position: Q1 2022 in Review

Millennium Management sold out of PLx Pharma Inc. Common Stock (PLXP) in Q1 2022, closing a stake of 143,459 shares — an estimated $1.15M sold.

Millennium Management first reported a position in PLXP in Q1 2014 and held it in 15 quarters. The position peaked at $1.15M in Q4 2021. 50 funds tracked by Wall St. Rank hold PLXP as of Q1 2022.

  • Millennium Management reported no remaining PLx Pharma Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Millennium Management sold 143,459 PLx Pharma Inc. Common Stock shares in Q1 2022, an estimated $1.15M.
  • Millennium Management first reported a position in PLx Pharma Inc. Common Stock in Q1 2014 and held it in 15 quarters.
  • Millennium Management's PLx Pharma Inc. Common Stock position peaked at $1.15M in Q4 2021.
  • 50 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q1 2022.

Based on Millennium Management's 13F filing for Q1 2022, filed 16 May 2022.